Candida spp. airway colonization could promote antibiotic-resistant bacteria selection in patients with suspected

Maël Hamet1, Arnaud Pavon, Frédéric Dalle

  • 1Service de Réanimation Médicale, Hôpital Bocage Central, C.H.U. Dijon, 14 rue Gaffarel, B.P. 77908-21079, Dijon Cedex, France.

Abstract

Insights

Candida airway colonization is common in patients with suspected ventilator-associated pneumonia (VAP). This fungal presence increases the risk of multidrug-resistant (MDR) bacteria isolation and is linked to higher mortality rates.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Candida spp. airway colonization may precede Pseudomonas aeruginosa-associated ventilator-associated pneumonia (VAP).
  • Fungal colonization can potentially worsen VAP outcomes, irrespective of the primary pathogen.

Purpose of the Study:

  • To investigate the risk of multidrug-resistant (MDR) bacteria isolation in patients with suspected VAP.
  • To determine if Candida spp. airway colonization influences MDR bacteria isolation and patient outcomes.

Main Methods:

  • A prospective observational study was conducted in a teaching hospital.
  • Respiratory secretions from patients with suspected VAP were cultured for yeast and standard bacteria.
  • Outcomes and MDR bacteria presence were assessed in relation to fungal colonization.

Main Results:

  • Of 323 suspected VAP cases, 181 (56%) showed Candida spp. airway colonization.
  • Patients with fungal colonization had a higher mortality rate (44.2% vs. 31.0%) and a trend towards increased MDR bacteria isolation (31.5% vs. 23.2%).
  • Candida spp. colonization was an independent risk factor for MDR bacteria isolation (OR=1.79).

Conclusions:

  • Candida spp. airway colonization is frequent in suspected VAP and associated with a higher risk of MDR bacteria isolation.
  • This association suggests that fungal colonization may contribute to worse VAP outcomes.
  • Consideration of Candida colonization is recommended for empiric antibiotic therapy selection in VAP patients.

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...